1590.2000 5.40 (0.34%)
NSE Jun 06, 2025 15:31 PM
Volume: 940.3K
 

1590.20
0.34%
Motilal Oswal
India/Europe/API drive revenue growth: 1QFY20 revenues grew 7.3% YoY to INR22.8b (v/s est. INR25.9b), led by healthy growth in (a) Domestic Formulation (33% of sales), up 13.4% YoY to INR7.5b, (b) Europe business (11% of sales), up 10.5% YoY to INR2.4b, and (3) the API business (10% of sales), up ~10% YoY to INR2.3b. US business (32% of sales) grew at a subdued rate of 4% YoY to INR7.3b, (USD105m, flat on constant currency basis). RoW also grew moderately at 5.4% YoY to INR2.6b. Overall, revenue...
Glenmark Pharmaceuti.. has an average target of 1662.25 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended